Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma



Status:Recruiting
Conditions:Liver Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 100
Updated:3/10/2019
Start Date:October 11, 2017
End Date:June 30, 2021
Contact:AstraZeneca Clinical Study Information Center
Email:information.center@astrazeneca.com
Phone:1-877-240-9479

Use our guide to learn which trials are right for you!

A Randomized, Open-label, Multi-center Phase III Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

This is a randomized, open-label, multi-center, global, Phase III study to assess the
efficacy and safety of durvalumab plus tremelimumab combination therapy and durvalumab
monotherapy versus sorafenib in the treatment of patients with no prior systemic therapy for
unresectable HCC. The patients cannot be eligible for locoregional therapy.

The study population includes patients 18 years of age or older with advanced HCC, Barcelona
Clinic Liver Cancer stage B not eligible for locoregional therapy or stage C, and Child-Pugh
A classification liver disease. Patients must not have received any prior systemic therapy
for unresectable HCC.

Patients in all treatment arms may continue receiving their originally assigned treatment, at
the Investigator's discretion, until progression

Patients in all arms with confirmed PD who, in the Investigator's opinion, continue to
receive benefit from their assigned treatment and meet the criteria for treatment in the
setting of PD may continue to receive their assigned treatment.

If a patient discontinues study drug(s) due to disease progression, the patient will enter
survival follow-up. Patients who have discontinued treatment due to toxicity or symptomatic
deterioration or who have commenced subsequent anticancer therapy, will have tumor
assessments until confirmed PD and will be followed for survival.

Inclusion criteria

- HCC based on histopathological confirmation

- No prior systemic therapy for HCC

- Barcelona Clinic Liver Cancer (BCLC) stage B (that is not eligible for locoregional
therapy) or stage C

- Child-Pugh Score class A

- ECOG performance status of 0 or 1 at enrollment

Exclusion criteria

- Hepatic encephalopathy within past 12 months or requirement for medication to prevent
or control encephalopathy

- Clinically meaningful ascites

- Main portal vein tumor thrombosis

- Active or prior documented GI bleeding (eg, esophageal varices or ulcer bleeding)
within 12 months

- HBV and HVC co-infection, or HBV and Hep D co-infection
We found this trial at
33
sites
Saint Petersburg, Florida 33713
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Barretos,
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
?
mi
from
Germantown, TN
Click here to add this to my saved trials
?
mi
from
Hartford, CT
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Morgantown, WV
Click here to add this to my saved trials
?
mi
from
Murray, UT
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Orange, CA
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Portland, OR
Click here to add this to my saved trials
?
mi
from
Rochester, MN
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
?
mi
from
Washington,
Click here to add this to my saved trials
?
mi
from
Westwood, KS
Click here to add this to my saved trials